Venture Challenge alumnus Praxa Sense initiates first clinical trial

Last month, Praxa Sense has started the first clinical trial with their Afi product at Reinier de Graaf ziekenhuis. Afi, their remote health monitoring device, is researched as investigative device in clinical practice with patients that suffer from atrial fibrillation. By now, more than 20 patients have been included. In total 165 patients will be included in the study.

Leonard Moonen, CEO Praxa Sense commented: It's really a challenge to organize and coordinate research activities during COVID times, so we are really happy we made it!

Praxa Sense

‹ News overview